Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny M Heaton

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Pediatric Infectious Disease Journal|June 29, 2006
The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortantsH Fred Clark, Paul A Offit, Stanley A Plotkin, et al.
The Journal of Infectious Diseases|August 10, 2005
Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritisPenny M Heaton, Michelle G Goveia, Jacqueline M Miller, et al.
Clinical Pharmacology and Therapeutics|March 25, 2023
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development PerspectivePenny M Heaton, Kavitha Palaniappan, Anne-Claire Stona, et al.
The Pediatric Infectious Disease Journal|June 4, 2008
Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.
Plos One|June 26, 2009
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferretsTed M Ross, Kutub Mahmood, Corey J Crevar, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
The Pediatric Infectious Disease Journal|August 30, 2008
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccineMax Ciarlet, Ramei Sani-Grosso, Guojun Yuan, et al.
The Pediatric Infectious Disease Journal|May 9, 2007
Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United StatesZoe M Rodriguez, Michelle G Goveia, Jon E Stek, et al.
The Pediatric Infectious Disease Journal|November 29, 2007
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infantsMichelle G Goveia, Zoe M Rodriguez, Michael J Dallas, et al.
The Lancet. Global Health|October 22, 2018
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyDimitrios Gouglas, Tung Thanh Le, Klara Henderson, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Pediatric Infectious Disease Journal|June 29, 2006
The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortantsH Fred Clark, Paul A Offit, Stanley A Plotkin, et al.
The Journal of Infectious Diseases|August 10, 2005
Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritisPenny M Heaton, Michelle G Goveia, Jacqueline M Miller, et al.
Clinical Pharmacology and Therapeutics|March 25, 2023
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development PerspectivePenny M Heaton, Kavitha Palaniappan, Anne-Claire Stona, et al.
The Pediatric Infectious Disease Journal|June 4, 2008
Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.
Plos One|June 26, 2009
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferretsTed M Ross, Kutub Mahmood, Corey J Crevar, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
The Pediatric Infectious Disease Journal|August 30, 2008
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccineMax Ciarlet, Ramei Sani-Grosso, Guojun Yuan, et al.
The Pediatric Infectious Disease Journal|May 9, 2007
Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United StatesZoe M Rodriguez, Michelle G Goveia, Jon E Stek, et al.
The Pediatric Infectious Disease Journal|November 29, 2007
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infantsMichelle G Goveia, Zoe M Rodriguez, Michael J Dallas, et al.
The Lancet. Global Health|October 22, 2018
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyDimitrios Gouglas, Tung Thanh Le, Klara Henderson, et al.
Pageof 4